Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Quotient Clinical incorporates Japanese bridging into a Translational Pharmaceutics® programQuotient Clinical, the Translational Pharmaceutics company, has announced the completion of its first clinical program involving Japanese healthy volunteers.
By: Quotient Clinical The Japanese market is one of the leading pharmaceutical markets worldwide, and bridging studies conducted outside of Japan ensure that drugs that are to be marketed in Japan have been thoroughly evaluated in the Japanese population. This program of work was a first-in-human (http://www.quotientclinical.com/ The program was delivered using Quotient's Translational Pharmaceutics® Ian Nisbet, VP Clinical Operations, said "We are delighted to extend our core Translational Pharmaceutics services to now include Japanese volunteers. Recruitment was undertaken in partnership with UK Chiken Services Ltd, an experienced company which specialises in Japanese volunteer recruitment. All cohorts were dosed on time and in full." End
Account Email Address Disclaimer Report Abuse
|
|